<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(2)</volume><submitter>Sun HJ</submitter><pubmed_abstract>Neuroinflammation has been well recognized as a key pathological event in acute glaucoma. The medical therapy of acute glaucoma mainly focuses on lowering intraocular pressure (IOP), while there are still scarce anti-inflammatory agents in the clinical treatment of acute glaucoma. Here we reported that β,3α,5α-trihydroxy-androst-6-one (sterone), a novel synthetic polyhydric steroid, blocked neuroinflammation mediated by microglia/macrophages and alleviated the loss of retinal ganglion cells (RGCs) caused by acute intraocular hypertension (AIH). The results showed that sterone significantly inhibited the morphological changes, the up-regulation of inflammatory biomarker ionized calcium-binding adapter molecule 1 (Iba-1), and the mRNA increase of proinflammatory tumor necrosis factor-α (TNF-</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>E252</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6358879</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia.</pubmed_title><pmcid>PMC6358879</pmcid><pubmed_authors>Yin W</pubmed_authors><pubmed_authors>Sheng LX</pubmed_authors><pubmed_authors>Zhu Z</pubmed_authors><pubmed_authors>Yan GM</pubmed_authors><pubmed_authors>Lu BZ</pubmed_authors><pubmed_authors>Zhou YW</pubmed_authors><pubmed_authors>Xue DD</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Chen YP</pubmed_authors><pubmed_authors>Sun HJ</pubmed_authors><pubmed_authors>Zhang JX</pubmed_authors><pubmed_authors>Lin GJ</pubmed_authors><pubmed_authors>Lin SZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia.</name><description>Neuroinflammation has been well recognized as a key pathological event in acute glaucoma. The medical therapy of acute glaucoma mainly focuses on lowering intraocular pressure (IOP), while there are still scarce anti-inflammatory agents in the clinical treatment of acute glaucoma. Here we reported that β,3α,5α-trihydroxy-androst-6-one (sterone), a novel synthetic polyhydric steroid, blocked neuroinflammation mediated by microglia/macrophages and alleviated the loss of retinal ganglion cells (RGCs) caused by acute intraocular hypertension (AIH). The results showed that sterone significantly inhibited the morphological changes, the up-regulation of inflammatory biomarker ionized calcium-binding adapter molecule 1 (Iba-1), and the mRNA increase of proinflammatory tumor necrosis factor-α (TNF-</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-04-18T16:31:53.252Z</modification><creation>2019-03-26T22:53:18Z</creation></dates><accession>S-EPMC6358879</accession><cross_references><pubmed>30641903</pubmed><doi>10.3390/molecules24020252</doi></cross_references></HashMap>